Xvivo Perfusion AB (OSTO:XVIVO) EV-to-Revenue : 17.31 (As of Apr. 25, 2024)

View and export this data going back to 2012. Start your Free Trial

What is Xvivo Perfusion AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Xvivo Perfusion AB's enterprise value is kr11,127.3 Mil. Xvivo Perfusion AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr642.9 Mil. Therefore, Xvivo Perfusion AB's EV-to-Revenue for today is 17.31.

The historical rank and industry rank for Xvivo Perfusion AB's EV-to-Revenue or its related term are showing as below:

OSTO:XVIVO' s EV-to-Revenue Range Over the Past 10 Years
Min: 7.32 Med: 15.62 Max: 58.44
Current: 17.31

During the past 12 years, the highest EV-to-Revenue of Xvivo Perfusion AB was 58.44. The lowest was 7.32. And the median was 15.62.

OSTO:XVIVO's EV-to-Revenue is ranked worse than
89.45% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: 3.07 vs OSTO:XVIVO: 17.31

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Xvivo Perfusion AB's stock price is kr368.50. Xvivo Perfusion AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr21.15. Therefore, Xvivo Perfusion AB's PS Ratio for today is 17.42.

Xvivo Perfusion AB EV-to-Revenue Historical Data

The historical data trend for Xvivo Perfusion AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB EV-to-Revenue Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

19.78

48.21

30.27

12.58

16.51

Xvivo Perfusion AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															15.92	17.06	14.09	16.51	12.73

Competitive Comparison of Xvivo Perfusion AB's EV-to-Revenue

For the Medical Devices subindustry, Xvivo Perfusion AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xvivo Perfusion AB's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's EV-to-Revenue falls into.

Xvivo Perfusion AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Xvivo Perfusion AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	11127.312	/	642.949
	=	17.31

Xvivo Perfusion AB's current Enterprise Value is kr11,127.3 Mil.
Xvivo Perfusion AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr642.9 Mil.

Xvivo Perfusion AB (OSTO:XVIVO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Xvivo Perfusion AB's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	368.50	/	21.149
	=	17.42

Xvivo Perfusion AB's share price for today is kr368.50.
Xvivo Perfusion AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr21.15.

Xvivo Perfusion AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

XVIPF:USA 3XV:Germany

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines